The AHA is interested in the science community exploring the etiology, prevention or treatment of cardiovascular disease or stroke in Atrial Fibrillation, which can assist the AHA in reaching its 2020 Goals and overall mission of building healthier lives free of cardiovascular disease and stroke. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population. The Korean Heart Rhythm Society organized a Korean AF Management Guideline Committee and analyzed all available studies regarding the management of AF, including studies on Korean patients. This guide … 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society 2019 ACC-AHA Atrial Fibrillation Guideline •Purpose of the update New evidence, medications and devices since 2014 •Guideline updates focused on anticoagulation CHA 2 DS 2-VASc score risk stratification changes Anticoagulant choices in end-stage renal disease or hemodialysis •Refer to 2014 Atrial Fibrillation Guidelines for Atrial fibrillation is the most common complication after heart surgery. It occurs in 15% to 40% of patients, usually shortly after surgery. After treatment, the heart typically goes back to its Both guidelines agree that rate control is preferred to rhythm control in most patients with atrial fibrillation. The AHA/ACC/HRS guideline recommends controlling ventricular rate using a beta Atrial fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. An arrhythmia is when the heart beats too slowly, too fast, or in an irregular way. When a person has AFib, the normal beating in the upper chambers of the heart (the two atria) is irregular, and blood doesn't flow as well as it should from the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope; 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation; 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Atrial fibrillation (AF) poses a significant burden to patients, physicians, and healthcare systems globally. Substantial research efforts and resources are being directed towards gaining detailed information about the mechanisms underlying AF, its natural course and effective treatments. New evidence is continuously generated and published. This guideline update provides up-to-date comprehensive recommendations for the management and treatment of persons with acute arterial ischemic stroke. Audiences for this guideline are: prehospital care providers, physicians, nurses, allied health professionals and hospital administrators. The 2018 guideline addresses the practical management of patients with high blood cholesterol and related disorders. Recommendations are based on the best available evidence from randomized controlled trials of cholesterol-lowering therapies and other sources of evidence. This guideline is a full update of the 2013 ACC/AHA cholesterol guideline. Top Things to Know: 2019 AHA/ACC/HRS Focused Update of the Guideline for the Management of Patients With Atrial Fibrillation; Slide Set: 2019 Focused Update of the 2014 Atrial Fibrillation Guideline (PDF) News Release: Updated treatment guideli